Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review
Jiawen Song, Yushi Liu, Yurou Guo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1743-1757
Closed Access | Times Cited: 10
Multi-omics analysis of genetic differences between Guangchenpi and Huajuhong
Yiyun Wang, Rong Huang, Song Gao, et al.
Scientia Horticulturae (2025) Vol. 342, pp. 113838-113838
Open Access | Times Cited: 1
General expert consensus on the application of network pharmacology in the research and development of new traditional Chinese medicine drugs
Li Shao, Wei Xiao
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 2, pp. 129-142
Closed Access | Times Cited: 1
Rational design of phytovirucide inhibiting nucleocapsid protein aggregation in tomato spotted wilt virus
Ningning Zan, Jiao Li, Jiahui Yao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Echinatin alleviates inflammation and pyroptosis in hypoxic-ischemic brain damage by inhibiting TLR4/ NF-κB pathway
Xiaoyue Tao, Yingying Hu, Niping Mao, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112372-112372
Closed Access | Times Cited: 8
Antioxidant effects of Paeoniflorin and relevant molecular mechanisms as related to a variety of diseases: A review
Yansong Lu, Lu Yin, Wei Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116772-116772
Open Access | Times Cited: 6
A comprehensive review on pharmacokinetic mechanism of herb-herb/drug interactions in Chinese herbal formula
Mengting Li, Yanli Wang, Yi Chen, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108728-108728
Closed Access | Times Cited: 6
Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
Xiaoning Gao, WuYan Guo, Peiyuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
Rui Zhang, Haohao Yan, Jiahao Zhou, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 5
Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine
Jingqi Zeng, Xiao‐Bin Jia
Engineering (2024) Vol. 40, pp. 28-50
Open Access | Times Cited: 5
Potential therapeutic effects of traditional Chinese medicine in acute mountain sickness: pathogenesis, mechanisms and future directions
Zhenhui Wu, Yihao Wang, Rong Gao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Ferroptosis is involved in quercetin-mediated alleviation of Ochratoxin A-induced kidney damage
Yuanli Zhou, Wei Lü, Kehe Huang, et al.
Food and Chemical Toxicology (2024) Vol. 191, pp. 114877-114877
Closed Access | Times Cited: 5
Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease
Haohao Yan, Rui Zhang, Xiaoping Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 37
Open Access | Times Cited: 12
Paving new roads toward the advancement of broad‐spectrum antiviral agents
Ruikun Du, Jazmin Galván Achi, Qinghua Cui, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 4
The quality evaluation of 30 Asparagus officinalis L. varieties
Rui Gao, Guanghui Li, Pingxiang Liu, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 4, pp. 2908-2916
Open Access | Times Cited: 4
Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine
Quan Gao, Hao Wu, Min Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir–ritonavir in adult patients with COVID-19: A randomized, open-label, multicenter trial
Xiaohui Zou, Kang Chang, Guohui Fan, et al.
Science Bulletin (2024) Vol. 69, Iss. 12, pp. 1954-1963
Open Access | Times Cited: 4
EGCG drives gut microbial remodeling-induced epithelial GPR43 activation to lessen Th1 polarization in colitis
Siyan Che, Beibei Qin, Kunfu Wu, et al.
Redox Biology (2024) Vol. 75, pp. 103291-103291
Open Access | Times Cited: 4
Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
Efficacy and mechanism of Qianjinweijing Decoction for asthma: Integrating systematic review with meta-analysis and network pharmacology
Limin Zhang, Jin Su, Xiaozheng Wu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41317-e41317
Open Access
Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
Muzaffar Kayumov, Parthiban Marimuthu, Jamoliddin Razzokov, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Uncovering the antidepressant active ingredients and related molecular mechanisms of Xiaoyao pill using integrated pharmacological strategy
Siqian Zhou, Yajing Wang, Xie Mingxia, et al.
Journal of Chromatography B (2025) Vol. 1255, pp. 124502-124502
Open Access
A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
Yu Yuan, Lu-Lu Yu, Chenghao Bi, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
The next viral pandemic—where do we stand?
Rui Fan, Qingfen Liang, Yue Sui, et al.
Folia Microbiologica (2025)
Closed Access
Methyl rosmarinate is an allosteric inhibitor of SARS-cov-2 3 C L protease as a potential candidate against SARS-cov-2 infection
Hongtao Li, Meng Sun, Fuzhi Lei, et al.
Antiviral Research (2024) Vol. 224, pp. 105841-105841
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top